Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant adverse » significant advantage (Expand Search)
significant bins » significant bias (Expand Search), significant bit (Expand Search), significant hits (Expand Search)
Showing 1 - 20 results of 24 for search '(( significant decrease decrease ) OR ( ((significant adverse) OR (significant bins)) decrease ))~', query time: 0.48s Refine Results
  1. 1
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  2. 2
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  3. 3
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  5. 5
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  6. 6
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  8. 8
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    Save to List
    Saved in:
  9. 9
    Baseline characteristics of cases and controls.

    Baseline characteristics of cases and controls. by Soo Min Ahn (10333246)

    Published 2025
    Save to List
    Saved in:
  10. 10
    Table 1_Inverse association between triglyceride–glucose index and maximal oxygen uptake in US young and middle-aged population: a cross-sectional study.docx

    Table 1_Inverse association between triglyceride–glucose index and maximal oxygen uptake in US young and middle-aged population: a cross-sectional study.docx by Bin Zhang (64682)

    Published 2025
    Save to List
    Saved in:
  11. 11
    Table 1_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.docx

    Table 1_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.docx by Yongyi Zhang (1800337)

    Published 2025
    Save to List
    Saved in:
  12. 12
    Table 2_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.docx

    Table 2_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.docx by Yongyi Zhang (1800337)

    Published 2025
    Save to List
    Saved in:
  13. 13
    Image 3_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.jpeg

    Image 3_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.jpeg by Yongyi Zhang (1800337)

    Published 2025
    Save to List
    Saved in:
  14. 14
    Image 1_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif

    Image 1_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif by Yongyi Zhang (1800337)

    Published 2025
    Save to List
    Saved in:
  15. 15
    Image 2_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif

    Image 2_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif by Yongyi Zhang (1800337)

    Published 2025
    Save to List
    Saved in:
  16. 16
    Image 4_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif

    Image 4_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif by Yongyi Zhang (1800337)

    Published 2025
    Save to List
    Saved in:
  17. 17
    Data Sheet 1_Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab.pdf

    Data Sheet 1_Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituxim... by Jing Zhou (168494)

    Published 2025
    Save to List
    Saved in:
  18. 18
    Table 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.docx

    Table 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.docx by Yazhao Mei (13041882)

    Published 2025
    “…Vertebral area loss decreased significantly with denosumab (-14.6%, P=0.029), unlike alendronate (-8.8%, P=0.296). …”
    Save to List
    Saved in:
  19. 19
    Image 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.tif

    Image 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.tif by Yazhao Mei (13041882)

    Published 2025
    “…Vertebral area loss decreased significantly with denosumab (-14.6%, P=0.029), unlike alendronate (-8.8%, P=0.296). …”
    Save to List
    Saved in:
  20. 20
    Image 2_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.tif

    Image 2_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.tif by Yazhao Mei (13041882)

    Published 2025
    “…Vertebral area loss decreased significantly with denosumab (-14.6%, P=0.029), unlike alendronate (-8.8%, P=0.296). …”
    Save to List
    Saved in:

Search Tools: